Skip to content
Create account to build your panelHelp me choose

Autoimmune Blood Tests: When Your Body Attacks Itself

By the EllaDx team · Updated November 5, 2026 · 5 min read

For education only, not a diagnosis. Talk to your clinician about your results.

Woman with her eyes closed, stretching one arm overhead by the water
← Back to Journal

Autoimmune conditions affect women more than men. One review estimated that 78% of people with autoimmune disease are women (Fairweather et al., 2004), and most of the conditions in a US review were more common in women (Jacobson et al., 1997). In a UK study of 22 million people, about 64% of those newly diagnosed were female (Conrad et al., 2023). If you have unexplained symptoms, a clinician can help you decide whether autoimmune testing makes sense.

What Are Autoimmune Diseases?

In autoimmune conditions, your immune system mistakenly attacks your own tissues. There are at least 80 types (Rose, 2016), including:

  • Hashimoto's thyroiditis
  • Rheumatoid arthritis
  • Lupus
  • Celiac disease
  • Multiple sclerosis
  • Type 1 diabetes

Common Autoimmune Symptoms

  • Fatigue
  • Joint pain and swelling
  • Skin problems
  • Digestive issues
  • Recurring fever
  • Swollen glands

Autoimmune Screening Tests

ANA (Antinuclear Antibody)

A first test for people with signs and symptoms of a systemic rheumatic disease, such as lupus. Guidance stresses using it only when the result can help with a clinical decision (Kavanaugh et al., 2000). A positive ANA may not mean disease. In a US national survey, 13.8% of people ages 12 and older had a positive result (Satoh et al., 2012), and positive results at low levels turned up in healthy people too (Tan et al., 1997). A clinician can decide whether further testing is needed.

Specific Antibodies

  • Thyroid antibodies (TPO, TgAb) - may point to Hashimoto's (Parveen et al., 2026)
  • RF and anti-CCP - may point to rheumatoid arthritis. Anti-CCP was the more specific of the two in a meta-analysis, and each test missed about 1 in 3 people with the disease (Nishimura et al., 2007)
  • Anti-dsDNA, Anti-Smith - may point to lupus. Lupus-specific antibodies are part of the current lupus classification criteria, which also require a positive ANA (Aringer et al., 2019)
  • Anti-tTG, Anti-EMA - may point to celiac disease. Most patients still need an intestinal biopsy to confirm it (Rubio-Tapia et al., 2023)

Inflammatory Markers

  • CRP (C-reactive protein)
  • ESR (sed rate)
  • Ferritin (can be elevated in inflammation)

Important Notes

  • Autoimmune diseases can cluster, both in the same person (Conrad et al., 2023) and within families (Cárdenas-Roldán et al., 2013)
  • Diagnosis can take time. In a large Latin American lupus study, half of patients waited more than 6 months from first symptoms (Nieto et al., 2024)
  • Early treatment can matter in some conditions, though the research doesn't all agree. In a small rheumatoid arthritis study, people treated about 3 months after onset did better than those treated at about 12 months (Nell et al., 2004). In the lupus study, a longer wait for diagnosis, of up to 24 months, had no clear effect on damage or survival (Nieto et al., 2024)
  • Lifestyle can affect some conditions. Smoking has been linked with poorer outcomes in rheumatic diseases, including higher disease activity in early rheumatoid arthritis (Wieczorek et al., 2022)

References

  • Jacobson, D. L., et al. (1997). Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clinical Immunology and Immunopathology, 84(3), 223-243. PMID 9281381
  • Fairweather, D., & Rose, N. R. (2004). Women and autoimmune diseases. Emerging Infectious Diseases, 10(11), 2005-2011. PMID 15550215
  • Conrad, N., et al. (2023). Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet, 401(10391), 1878-1890. PMID 37156255
  • Rose, N. R. (2016). Prediction and Prevention of Autoimmune Disease in the 21st Century: A Review and Preview. American Journal of Epidemiology, 183(5), 403-406. PMID 26888748
  • Kavanaugh, A., et al. (2000). Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Archives of Pathology and Laboratory Medicine, 124(1), 71-81. PMID 10629135
  • Satoh, M., et al. (2012). Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis and Rheumatism, 64(7), 2319-2327. PMID 22237992
  • Tan, E. M., et al. (1997). Range of antinuclear antibodies in "healthy" individuals. Arthritis and Rheumatism, 40(9), 1601-1611. PMID 9324014
  • Parveen, N., et al. (2026). Pragmatic Use of Thyroid Autoantibodies in Clinical Practice: An Update. TouchREVIEWS in Endocrinology, 22(1), 37-44. PMID 42273002
  • Nishimura, K., et al. (2007). Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Annals of Internal Medicine, 146(11), 797-808. PMID 17548411
  • Aringer, M., et al. (2019). 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis and Rheumatology, 71(9), 1400-1412. PMID 31385462
  • Rubio-Tapia, A., et al. (2023). American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease. American Journal of Gastroenterology, 118(1), 59-76. PMID 36602836
  • Cárdenas-Roldán, J., et al. (2013). How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Medicine, 11, 73. PMID 23497011
  • Nieto, R., et al. (2024). Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort. Lupus, 33(4), 340-346. PMID 38334100
  • Nell, V. P., et al. (2004). Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology, 43(7), 906-914. PMID 15113999
  • Wieczorek, M., et al. (2022). Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs. RMD Open, 8(1), e002170. PMID 35351808